Tucatinib
Back to searchMolecule Structure
Scientific Name
Tucatinib
Description of the Drug
Tucatinib is a kinase inhibitor used to treat certain types of unresectable/metastatic HER-2 positive breast cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11652
http://www.drugbank.ca/drugs/DB11652
Brand Name(s)
Tukysa
Company Owner(s)
Seagen Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Receptor protein-tyrosine kinase erbB-2 | SINGLE PROTEIN | INHIBITOR | CHEMBL1824 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1193050 | |
| Human Metabolome Database | HMDB0304868 | |
| DrugBank | DB11652 | |
| PubChem: Thomson Pharma | 117699612 | |
| PubChem | 51039094 | |
| BindingDB | 471617 | |
| DrugCentral | 5389 | |
| ChemicalBook | CB32616075 | |
| Guide to Pharmacology | 9922 | |
| rxnorm | TUKYSA | TUCATINIB |
| ZINC | ZINC000068250462 |
